A phase 3 clinical trial found that the cell therapy deramiocel may slow muscle weakening and heart damage in boys and young men with advanced Duchenne muscular dystrophy. …
Older adults with remarkable memory abilities, known as superagers, are more likely to have greater movement speed and better mental health compared to typical older adults. …
A large Dutch study suggests that one in eight adults (12.7%) infected with SARS-CoV-2 experience long COVID symptoms. …
New findings suggest severe COVID-19 is associated with an increased risk of long-term adverse mental health effects. …
Two doses of the Pfizer-BioNTech COVID-19 vaccine are 90% effective against hospitalizations for all variants, including delta, for at least six months. …
An international group of scientists concludes that vaccine efficacy against severe COVID-19 is so high that booster doses for the general population are not appropriate at this stage in the pandemic. …
People infected with the SARS-CoV-2 delta variant have approximately double the risk of hospitalization …
An observational study of more than 3,000 healthy members of the US Marines Corps finds that a past COVID-19 infection does not completely protect against reinfection. …
Higher vaccine efficacy is obtained with a longer interval between the first and second dose of the Oxford COVID-19 vaccine. …
Preliminary findings from the phase 3 trial of the Russian COVID-19 vaccine (Gam-COVID-Vac) suggests that a two-dose regimen is 91.6 percent effective against symptomatic COVID-19. …
End of content
End of content
